Skip to content
10-Q

Quarterly Report

Agile Therapeutics, Inc.

0001558370-23-018603

← back to feed
Filed
Nov 9, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 7, 2023 2.51M sh
Shares Diluted Q3 2023 · Sep 30, 2023 2.95M sh
Shares Diluted Q3 2023 · Sep 30, 2023 1.88M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 739.96K sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 299.97K sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$9.75M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$34.39M
Short Term Debt Q3 2023 · Sep 30, 2023 $1.59M
Short Term Debt Q3 2023 · Dec 31, 2022 $1.43M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $2.87M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $5.25M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$12.41M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$12.12M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$9.43M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$5.55M
Stockholders Equity restated Q3 2023 · Sep 30, 2022 −$3.03M
Stockholders Equity restated Q3 2023 · Jun 30, 2022 $2.37M
Stockholders Equity restated Q3 2023 · Mar 31, 2022 −$5.36M
Stockholders Equity restated Q3 2023 · Dec 31, 2021 $3.92M
Current Liabilities Q3 2023 · Sep 30, 2023 $17.54M
Current Liabilities Q3 2023 · Dec 31, 2022 $13.39M
Total Liabilities Q3 2023 · Sep 30, 2023 $23.3M
Total Liabilities Q3 2023 · Dec 31, 2022 $19.79M
Current Assets Q3 2023 · Sep 30, 2023 $10.06M
Current Assets Q3 2023 · Dec 31, 2022 $11.36M
Total Assets Q3 2023 · Sep 30, 2023 $10.89M
Total Assets Q3 2023 · Dec 31, 2022 $14.24M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.27
Eps Diluted Q3 2023 · Sep 30, 2023 −$5.30
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$8.01
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$71.61
Eps Basic Q3 2023 · Sep 30, 2023 −$0.27
Eps Basic Q3 2023 · Sep 30, 2023 −$5.30
Eps Basic restated Q3 2023 · Sep 30, 2022 −$8.01
Eps Basic restated Q3 2023 · Sep 30, 2022 −$71.61
Sga Expense Q3 2023 · Sep 30, 2023 $2.68M
Sga Expense Q3 2023 · Sep 30, 2023 $8.81M
Sga Expense Q3 2023 · Sep 30, 2022 $2.82M
Sga Expense Q3 2023 · Sep 30, 2022 $9.84M
Rd Expense Q3 2023 · Sep 30, 2023 $705K
Rd Expense Q3 2023 · Sep 30, 2023 $2.17M
Rd Expense Q3 2023 · Sep 30, 2022 $788K
Rd Expense Q3 2023 · Sep 30, 2022 $2.9M
Net Income Q3 2023 · Sep 30, 2023 −$799K
Net Income Q3 2023 · Sep 30, 2023 −$10M
Net Income Q3 2023 · Jun 30, 2023 −$3.81M
Net Income Q3 2023 · Mar 31, 2023 −$5.39M
Net Income restated Q3 2023 · Sep 30, 2022 −$5.93M
Net Income restated Q3 2023 · Sep 30, 2022 −$21.48M
Net Income restated Q3 2023 · Jun 30, 2022 −$5.17M
Net Income restated Q3 2023 · Mar 31, 2022 −$10.39M
Operating Income Q3 2023 · Sep 30, 2023 −$4M
Operating Income Q3 2023 · Sep 30, 2023 −$15.83M
Operating Income Q3 2023 · Sep 30, 2022 −$18.71M
Operating Income Q3 2023 · Sep 30, 2022 −$45.68M
Gross Profit Q3 2023 · Sep 30, 2023 $4.19M
Gross Profit Q3 2023 · Sep 30, 2023 $9.19M
Gross Profit Q3 2023 · Sep 30, 2022 $1.58M
Gross Profit Q3 2023 · Sep 30, 2022 $1.71M
Cost Of Revenue Q3 2023 · Sep 30, 2023 $2.48M
Cost Of Revenue Q3 2023 · Sep 30, 2023 $6.79M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $1.43M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $5.18M
Revenue Q3 2023 · Sep 30, 2023 $6.66M
Revenue Q3 2023 · Sep 30, 2023 $15.98M
Revenue Q3 2023 · Sep 30, 2022 $3M
Revenue Q3 2023 · Sep 30, 2022 $6.89M
Capex Q3 2023 · Sep 30, 2022 $133K